Rice University has launched RBL LLC, a biotech venture creation studio aimed at enhancing patient care. The initiative is designed to swiftly develop companies that focus on lifesaving medical technologies originating from the Rice Biotech Launch Pad, the university’s accelerator for biotech innovation established last year.
The Rice Biotech Launch Pad will continue to provide RBL with fully developed and de-risked technologies from Rice’s life sciences portfolio, serving as a steady innovation pipeline for new ventures.
RBL will work to fast-track the journey “from bench to bedside” by leveraging a large portfolio of more than 100 patents from Rice faculty, bringing together scientists and engineers with experienced business executives to launch companies in a thriving biotech innovation environment.
Located in Houston’s Texas Medical Center Helix Park, RBL bridges the gap between academic biotech discoveries and the clinical care market. RBL’s location within the TMC provides greater opportunity to collaborate with premier clinical centers, corporate partners and global investors—all within the same complex—to rapidly bring therapies to patients by directly transforming Rice’s most promising life science technology into high impact ventures, company leaders said.
Full story: Rice University Starts Up Biotech Venture Creation Enterprise for Medtech – Medical Product Outsourcing
